Prophylactic strategies to meet infectious complications in fludarabine-treated CLL

Leukemia

Volumn 11, Issue SUPPL. 2, 1997, Pages

  Sudhof T ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Chronic lymphocytic leukemia; Fludarabine; Opportunistic infections

Indexed keywords

CD4 ANTIGEN; CIPROFLOXACIN; CLADRIBINE; COTRIMOXAZOLE; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN; PENTOSTATIN; PREDNISONE; PURINE DERIVATIVE;

BACTERIAL INFECTION; BONE MARROW SUPPRESSION; CHEMOPROPHYLAXIS; CHRONIC LYMPHATIC LEUKEMIA; CONFERENCE PAPER; COST BENEFIT ANALYSIS; HUMAN; IMMUNE DEFICIENCY; IMMUNOTHERAPY; INFECTION PREVENTION; INFECTIOUS COMPLICATION; LYMPHOCYTE SUBPOPULATION; MYCOSIS; NEUTROPENIA; OPPORTUNISTIC INFECTION; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS CARINII; PRIORITY JOURNAL;

EID: 0030927872     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. International Workshop on Chronic Lymphocytic Leukemia. Chronic lymphocytic leukemia: recommendation for diagnosis, staging and response criteria. Ann Intern Med 1989; 110: 236-233.
2. Rozman C, Montserral E. Chronic lymphocytic leukemia. New Engl J Med 1995; 333: 1052-1057.
3. Cheson BD. Chronic lymphoid leukemia. In: Abeloff MD, Airmitage JO, Lichter AS, Niederhube," JE (eds). Clinical Oncology. Churchili Livingstonc: New York, 1995, pp 1999-2017.